Synairgen (SNG) ORD GBP 0.01
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
4.63p
4.93p
10.62p
£9.38 million
4.63p
4.34p
3.00p
n/a
0.04p (0.87%) Previous:
0.04p
42,959
n/a
75,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2023 | 31/12/2022 |
|---|---|---|
| Revenue (£m) | n/a | n/a |
| Profit before tax (£m) | (9.66) | (20.09) |
| Adjusted EPS (p): | (4.18) | (8.76) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Synairgen names Joseph Colliver as CFO
11 October 2023 10:26
-
Synairgen posts positive results for phase 2 trial with SNG001 against Covid-19
4 October 2022 08:00
-
Synairgen unveils positive clinical trial data
7 September 2022 07:59
-
Exercise of Share Options and Total Voting Rights
30 October 2024 18:09
-
Results of AGM and Appointment of New Chairman
10 October 2024 17:05
-
Interim Results
26 September 2024 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.